Cerus
CERS
HK$11.38
Share price
-6.45%
Change (1 day)
-30.91%
Change (1 year)
Categories
Cerus (CERS) - Total debt
Total debt on the balance sheet as of March 2025 : HK$0.78 Billion
According to Cerus's latest financial reports the company's total debt is HK$0.78 Billion. A company’s total debt is the sum of all current and non-current debts.
Cerus - Total debt on balance sheet (from 1997 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | HK$0.76 B | 1.58% |
| 2023-12-31 | HK$0.74 B | 10% |
| 2022-12-31 | HK$0.68 B | -0.2% |
| 2021-12-31 | HK$0.68 B | 31.7% |
| 2020-12-31 | HK$0.51 B | 3.31% |
| 2019-12-31 | HK$0.50 B | 114.59% |
| 2018-12-31 | HK$0.23 B | 0.47% |
| 2017-12-31 | HK$0.23 B | 54.95% |
| 2016-12-31 | HK$0.15 B | -2.12% |
| 2015-12-31 | HK$0.15 B | 100.46% |
| 2014-12-31 | HK$76.57 M | 193.37% |
| 2013-12-31 | HK$26.1 M | -56.4% |
| 2012-12-31 | HK$59.87 M | 6.82% |
| 2011-12-31 | HK$56.04 M | 47.16% |
| 2010-12-31 | HK$38.08 M | 20366.62% |
| 2009-12-31 | HK$0.18 M | |
| 2008-12-31 | N/A | -100% |
| 2007-12-31 | HK$0.24 M | -72.34% |
| 2006-12-31 | HK$0.9 M | -97.65% |
| 2005-12-31 | HK$38.46 M | -87.31% |
| 2004-12-31 | HK$0.30 B | -29.99% |
| 2003-12-31 | HK$0.43 B | 108751.45% |
| 2002-12-31 | HK$0.39 M | -37.8% |
| 2001-12-31 | HK$0.63 M | -29.33% |
| 2000-12-31 | HK$0.9 M | -20.24% |
| 1999-12-31 | HK$1.13 M | |
| 1997-12-31 | HK$0.77 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Haemonetics HAE | HK$9.61 B | 1,131.61% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | HK$22.62 M | -97.10% | 🇺🇸 USA |
 Boston Scientific BSX | HK$91.90 B | 11,673.22% | 🇺🇸 USA |
 Utah Medical Products UTMD | HK$2.11 M | -99.73% | 🇺🇸 USA |